一树药业品牌怎么样 申请店铺

我要投票 一树药业在中草药行业中的票数:926 更新时间:2026-01-19
一树药业是哪个国家的品牌?「一树药业」是 贵州一树连锁药业有限公司 旗下著名品牌。该品牌发源于贵州,由创始人王春雷在1999-03-11期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力一树药业品牌出海!将品牌入驻外推网,定制一树药业品牌推广信息,可以显著提高一树药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

一树药业怎么样

贵州一树连锁药业有限公司,成立于1999年4月,企业名称取自管仲名言“一树一获,谷也;一树十获,木也;一树百获,人也”,秉承十年树木,百年树人的“以人为本”的发展理念,公司自成立之日起,就严格按照“高起点、高标准”的要求,将国外零售企业的先进管理经验和OEC管理模式有机结合,建立了一套先进的质量保证体系和管理体系,是贵州省实力强的药品零售企业、A级纳税信用企业,名列中国药品零售连锁企业百强,被行业知名媒体评价为“中国药品零售行业的海尔”。

贵州一树连锁药业有限公司以“追求卓越,不断创新”为企业发展的核心理念,率先在深圳成立了中国药店贸易联盟,开辟了中国大的平价药品采购联盟;与此同时,贵州一树还走出西部,向东部发达地区的江苏省等多家国有企业输出管理,成为西部零售企业向东部企业输出管理的“人”。

贵州一树的出色表现,受到了全球药品零售巨头SUPER—PHARM集团的青睐,成功合资后成立了SUPER—PHARM(中国)有限公司,将欧美发达国家的先进药品零售概念引进中国,以化妆品和个人护理品为主导的药妆新体验,以普及专业的健康服务,倡导时尚的消费形式的SUPER—PHARM(中国)的零售业态从此引领着中国药品零售行业的潮流。合资后的贵州一树成为了中国医药零售行业家真正意义上的中外合资企业,为贵州一树从西部走向全国实现自己的梦想打下坚实的基础。

Guizhou Yishu chain Pharmaceutical Co., Ltd. was founded in April 1999. The company name is taken from Guan Zhong's famous saying "one tree, one harvest, one valley; one tree, ten harvest, wood; one tree, one hundred harvest, people". Adhering to the development concept of "people-oriented" of ten years of trees and one hundred years of people, the company, since its establishment, has strictly followed the requirements of "high starting point, high standard" to integrate foreign retail enterprises With the combination of advanced management experience and OEC management mode, it has established an advanced quality assurance system and management system. It is a powerful drug retail enterprise and A-level tax credit enterprise in Guizhou Province, ranking among the top 100 drug retail chain enterprises in China, and appraised as "Haier of China's drug retail industry" by the well-known media in the industry. Guizhou Yishu chain Pharmaceutical Co., Ltd. takes "pursuit of excellence and continuous innovation" as the core concept of enterprise development, and takes the lead in establishing China pharmacy trade alliance in Shenzhen, opening up China's large affordable drug purchase alliance; at the same time, Guizhou Yishu also goes out of the west, exports management to Jiangsu Province and other state-owned enterprises in the eastern developed areas, and becomes a Western retail enterprise to the East The "people" in the export management of enterprises. Guizhou Yishu's outstanding performance has been favored by the global pharmaceutical retail giant super Pharm group. After the successful joint venture, super Pharm (China) Co., Ltd. was established, which introduced the advanced pharmaceutical retail concepts from developed countries in Europe and the United States into China. With cosmetics and personal care products as the leading New experience of cosmetics, professional health services are popularized, and the fashionable consumption form of super is advocated - from then on, pharm's retail format has led the trend of China's pharmaceutical retail industry. After the joint venture, Guizhou Yishu has become a real Sino foreign joint venture of Chinese pharmaceutical retail industry, laying a solid foundation for Guizhou Yishu to realize its dream from the west to the whole country.

本文链接: https://brand.waitui.com/9522d1856.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

非银存款同比少减二点八四万亿元,低基数扰动+股市活跃吸引资金涌入

近日,2025年12月金融数据发布。数据显示,12月非银存款减少3300亿元,同比少减2.84万亿元。作为券商等非银行金融机构在银行处的存款,非银存款的变化常常被认为与股市涨跌互有关联,因此此次非银存款少减2.84万亿元自然也引发了市场较大关注。记者梳理的券商分析师主流观点认为,12月数据的较大变化,缘于2024年低基数的扰动。2024年12月1日开始,非银同业存款利率被纳入自律管理,导致当月非银存款大幅减少3.17万亿元,创下历史单月最大规模的收缩。兴业研究张伟康认为,非银存款12月减少3300亿元,同比少减2.84万亿元,一方面是因为季度末理财产品回表,另一方面是股市活跃吸引了资金涌入。(证券时报)

2小时前

绩优基金2025年四季度调仓动向:聚焦景气度,优化AI持仓

随着公募基金2025年四季报的密集披露,众多绩优基金的持仓变动逐步浮出水面。总体而言,绩优基金普遍保持高仓位运作,并对持仓进行了调整。从具体调仓方向看,基金经理更加看重行业景气度,持仓逐步向AI相关产业链、创新药、机器人等板块迁移。不过,在AI相关产业中,对持仓标的进行了优化调整。(上证报)

2小时前

三星电子将在下一代芯片中采用混合键合技术NAND

三星电子将在下一代芯片中采用混合键合技术NAND。(新浪财经)

2小时前

热门产品掀起限购潮,基金公司差异化导购

2026开年以来,市场行情火热,多家基金公司却对旗下热门产品开启了限购模式。这一看似逆市操作的背后,既是避免基金规模快速扩张,从而摊薄现有基金持有人收益的需要,也是基金公司从规模导向向投资者回报导向转型的体现。记者梳理发现,限购的绩优基金,多聚焦在AI应用、商业航天等近期热门赛道,这些赛道交易近来较为拥挤。因此不少基金公司也在挖掘一些其他细分赛道的基金或是“固收+”、FOF等产品,为投资者均衡配置提供可选项。(中证报)

2小时前

热门公司老股受追捧,中国S市场潜在空间扩大

人形机器人、商业航天等赛道的热门公司老股转让,带火了S交易(私募股权二级市场交易)市场。“重启未盈利企业上市,极大提振了一级股权投资人的信心,这也传导到S交易市场,含热门公司量较大的S份额被市场追捧,交易活跃度上升。”近日在沪举办的第四届私募股权基金流动性峰会上,中保投资有限责任公司副总裁陈子昊说。与会人士纷纷预计,2025年中国S交易规模有望再创新高。根据此前数据,2025年前三季度,中国私募股权二级市场交易总笔数为867笔,同比增长234%;交易总规模约923亿元,同比增长182%。(证券时报)

2小时前

本页详细列出关于一树药业的品牌信息,含品牌所属公司介绍,一树药业所处行业的品牌地位及优势。
咨询